Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PAS219 is a small molecule compound classified as a benzoyl derivative and phosphinate/phosphate ester. Its chemical formula is C14H19O5P and it has a molecular weight of 298.27 g/mol[3][1][2]. The compound is also known by several synonyms reflecting its structure as a cyclohexylmethyl-substituted form of phenol phosphate. There are no reported clinical indications or approved uses for PAS219; it appears to be primarily referenced in chemical and drug discovery databases as a research or discovery agent[1][2]. No specific mechanism of action or therapeutic target has been established for this molecule.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on PAS219.